Skip to main content
Premium Trial:

Request an Annual Quote

Genomics One to Sell $538K Worth of Assets to Medicorp

NEW YORK, May 27 (GenomeWeb News) - Laval, Quebec-based Genomics One will sell about CA$677,330 ($538,204) worth of assets from its BioCan Scientific subsidiaries in Canadaand the USto Montreal-based Medicorp.


The closing of the sale is planned for March 31, at which time Medicorp will pay CA$500,000, leaving a balance of CA$177,300, which will be held in escrow for 90 days.


According to Genomics One, the pending sale will help the company to focus on entering into the biodefense market using mass spectrometry technology.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.